Sengent Therapeutics

Sengent Therapeutics is a San Diego-based biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for cancer. The company utilizes a proprietary platform designed to target complex protein-protein interactions and other challenging biological targets that have historically been difficult to drug. Led by a team of experienced drug hunters, Sengent is building a pipeline of precision oncology programs aimed at overcoming resistance mechanisms in solid tumors. Currently in the pre-clinical stage, the company focuses on high-impact pathways to deliver transformative treatments for patients with limited options. The organization was founded by industry veterans with a track record of success at major pharmaceutical firms, emphasizing a data-driven approach to drug discovery.